摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-[8',8'-difluoro-8'-(diethylphosphono)oct-1'-ynyl]-2-N-(N,N-dimethylaminomethylidene)-1N-(pivaloyloxy)methyl-9-deazaguanine | 1225194-34-2

中文名称
——
中文别名
——
英文名称
9-[8',8'-difluoro-8'-(diethylphosphono)oct-1'-ynyl]-2-N-(N,N-dimethylaminomethylidene)-1N-(pivaloyloxy)methyl-9-deazaguanine
英文别名
——
9-[8',8'-difluoro-8'-(diethylphosphono)oct-1'-ynyl]-2-N-(N,N-dimethylaminomethylidene)-1N-(pivaloyloxy)methyl-9-deazaguanine化学式
CAS
1225194-34-2
化学式
C27H40F2N5O6P
mdl
——
分子量
599.615
InChiKey
SUPWVGUYVSSMIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.65
  • 重原子数:
    41.0
  • 可旋转键数:
    14.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    128.11
  • 氢给体数:
    1.0
  • 氢受体数:
    9.0

反应信息

  • 作为反应物:
    描述:
    9-[8',8'-difluoro-8'-(diethylphosphono)oct-1'-ynyl]-2-N-(N,N-dimethylaminomethylidene)-1N-(pivaloyloxy)methyl-9-deazaguanine 在 palladium 10% on activated carbon 、 氢气 作用下, 以 甲醇氯仿 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 0.33h, 以84%的产率得到9-[8',8'-difluoro-8'-(diethylphosphono)octyl]-2-N-(N,N-dimethylaminomethylidene)-1N-(pivaloyloxy)methyl-9-deazaguanine
    参考文献:
    名称:
    Structural-based design and synthesis of novel 9-deazaguanine derivatives having a phosphate mimic as multi-substrate analogue inhibitors for mammalian PNPs
    摘要:
    9-(5',5'-Difluoro-5'-phosphonopentyl)-9-deazaguanine (DFPP-DG) was designed as a multi-substrate analogue inhibitor against purine nucleoside phosphorylase (PNP) on the basis of X-ray crystallographic data obtained for a binary complex of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine (DFPP-G) with calf-spleen PNP. DFPP-DG and its analogous compounds were synthesized by the Sonogashira coupling reaction between a 9-deaza-9-iodoguanine derivative and omega-alkynyldifluoromethylene phosphonates as a key reaction. The experimental details focused on the synthetic chemistry along with some insights into the physical and biological properties of newly synthesized DFPP-DG derivatives are disclosed. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.01.062
  • 作为产物:
    描述:
    9-[8',8'-difluoro-8'-(diethylphosphono)oct-1'-ynyl]-2-N-(N,N-dimethylaminomethylidene)-7-N-(2-nitrophenyl)sulfonyl-1N-(pivaloyloxy)methyl-9-deazaguaninepotassium carbonate苯硫酚 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.5h, 以100%的产率得到9-[8',8'-difluoro-8'-(diethylphosphono)oct-1'-ynyl]-2-N-(N,N-dimethylaminomethylidene)-1N-(pivaloyloxy)methyl-9-deazaguanine
    参考文献:
    名称:
    Structural-based design and synthesis of novel 9-deazaguanine derivatives having a phosphate mimic as multi-substrate analogue inhibitors for mammalian PNPs
    摘要:
    9-(5',5'-Difluoro-5'-phosphonopentyl)-9-deazaguanine (DFPP-DG) was designed as a multi-substrate analogue inhibitor against purine nucleoside phosphorylase (PNP) on the basis of X-ray crystallographic data obtained for a binary complex of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine (DFPP-G) with calf-spleen PNP. DFPP-DG and its analogous compounds were synthesized by the Sonogashira coupling reaction between a 9-deaza-9-iodoguanine derivative and omega-alkynyldifluoromethylene phosphonates as a key reaction. The experimental details focused on the synthetic chemistry along with some insights into the physical and biological properties of newly synthesized DFPP-DG derivatives are disclosed. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2010.01.062
点击查看最新优质反应信息

同类化合物

(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2 -(羟甲基)四氢呋喃-3-醇 鲁索替尼 鲁索利尼杂质C 酸蓝129:1 迪高替尼 诺那吡胺 螺[4.4]壬烷-1-酮,6-氨基-,(5S,6S)- 苯酚,2,4-二氯-5-肼-,单盐酸 苯并呋喃,2,3-二氢-3-(1-甲基乙基)- 芦可替尼杂质5 芦可替尼杂质3 芦可替尼杂质2 聚(氧代-1,2-乙二基),a-甲基-w-[[3,4,4,4-四氟-2-[1,2,2,2-四氟-1-(三氟甲基)乙基]-1,3-二(三氟甲基)-1-丁烯-1-基]氧代]- 维贝格龙 磷酸鲁索替尼 甲基7-(2-甲氧基乙基)-1,3-二甲基-2,4-二羰基-2,3,4,7-四氢-1H-吡咯并[2,3-D]嘧啶-6-羧酸酯 甲基6,7-二氢-5H-吡咯并[3,4-D]嘧啶-2-甲酸基酯 氰基酰胺,(1-甲基-2-吡咯烷亚基)-(9CI) 杂质TFTB 替诺福韦杂质113 托法替布杂质ZJT2-I 托法替尼杂质28 托法替尼杂质2 托伐替尼杂质T 异丙基2-氨基-4-甲氧基-7h-吡咯并[2,3-d]嘧啶-6-羧酸 巴里替尼杂质5 巴瑞替尼杂质9 巴瑞替尼 巴瑞克替尼杂质 巴瑞克替尼中间体3 巴瑞克替尼中间体1 外消旋鲁替替尼-d8 培美酸 培美曲塞杂质 吡啶,1-[(2,5-二甲基苯基)甲基]-1,2,3,6-四氢- 吡咯并[1,2-a]嘧啶-3-羧酸 吡咯并[1,2-F]嘧啶-3-甲酸乙酯 吡咯并[1,2-C]嘧啶-4-腈 吡咯并[1,2-A]嘧啶-6-羧酸 吡咯并[1,2-A]嘧啶-6-甲醛 叔丁基2-氨基-4-氯-5H-吡咯并[3,4-D]嘧啶-6(7H)-羧酸酯 叔丁基-4-氯-2-吗啉代-7H-吡咯并[2,3-D]嘧啶-7-甲酸甲酯 十二烷-1,12-二基二(苯甲基二甲基铵)二氯化 化合物PFE-360 亚乙基,2-氨基-1-(乙酯基<乙氧羰基>)-2-(甲酰基亚氨基)-,(2Z)-(9CI) 二环[2.2.1]庚-5-烯-2-羧酸,丁基酯,(1R,2R,4R)- [4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 [3-(4-氨基-7H-吡咯并[2,3-d]嘧啶-7-基)环戊基]甲醇 [1-(乙基磺酰基)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]氮杂环丁烷-3-基]乙腈磷酸盐 S-鲁索替尼